A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy.
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2017
At a glance
- Drugs Litronesib (Primary) ; Filgrastim; Ixabepilone; Pegfilgrastim
- Indications Breast cancer
- Focus Therapeutic Use
- 01 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Aug 2013 Planned End Date changed from 1 Jun 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.
- 04 Apr 2013 Planned End Date changed from 1 Mar 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.